Stephen Ethier to Disease Progression
This is a "connection" page, showing publications Stephen Ethier has written about Disease Progression.
Connection Strength
0.168
-
Amphiregulin as a novel target for breast cancer therapy. J Mammary Gland Biol Neoplasia. 2008 Jun; 13(2):171-9.
Score: 0.060
-
Identifying and validating causal genetic alterations in human breast cancer. Breast Cancer Res Treat. 2003 Apr; 78(3):285-7.
Score: 0.042
-
Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst. 1995 Jul 05; 87(13):964-73.
Score: 0.025
-
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013 Oct 14; 24(4):450-65.
Score: 0.022
-
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 2011 Oct 01; 71(19):6195-207.
Score: 0.019